An IQVIA executive just cashed out 558 shares worth $136K—just before the stock dipped. With a $38B market cap and $17B in revenue, IQVIA remains a powerhouse in life sciences analytics and clinical trials. The insider still holds nearly 3,000 shares valued at over $739K. Sold at a premium to recent closing prices, this move sparks investor curiosity amid IQVIA’s strong year-over-year growth. Insider transactions like this are always worth watching for long-term investors.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
